{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T02:29:23Z","timestamp":1786588163956,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":97,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004761","name":"the Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2023JJ40351"],"award-info":[{"award-number":["2023JJ40351"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004761","name":"the Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2024JJ9350"],"award-info":[{"award-number":["2024JJ9350"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004761","name":"the Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2023JJ30324"],"award-info":[{"award-number":["2023JJ30324"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Scientific Research Project of Hunan Provincial Health Commission","award":["B202217018341"],"award-info":[{"award-number":["B202217018341"]}]},{"name":"the Hunan Provincial Key Laboratory of Emergency Medicine for Children","award":["2018TP1028"],"award-info":[{"award-number":["2018TP1028"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-026-03182-6","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T09:04:48Z","timestamp":1778490288000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["EBV DNA load and cytokines guide risk-stratified treatment in pediatric EBV-associated hemophagocytic lymphohistiocytosis"],"prefix":"10.1186","volume":"23","author":[{"given":"Longlong","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuedan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haipeng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghui","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiulan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"issue":"15","key":"3182_CR1","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1182\/blood-2011-03-278127","volume":"118","author":"MB Jordan","year":"2011","unstructured":"Jordan MB, et al. How I treat hemophagocytic lymphohistiocytosis. Blood. 2011;118(15):4041\u201352.","journal-title":"Blood"},{"issue":"10","key":"3182_CR2","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1182\/blood.2025028762","volume":"147","author":"B Verkamp","year":"2026","unstructured":"Verkamp B, Jordan MB, Allen CE. Pediatric hemophagocytic lymphohistiocytosis: current conceptualization, diagnosis, and treatment. Blood. 2026;147(10):1019\u201336.","journal-title":"Blood"},{"issue":"6","key":"3182_CR3","first-page":"507","volume":"36","author":"X Zeng","year":"2015","unstructured":"Zeng X, et al. [Treatment outcomes and prognostic analysis of 61 Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis]. Zhonghua Xue Ye Xue Za Zhi. 2015;36(6):507\u201310.","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"5","key":"3182_CR4","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/bjh.15988","volume":"186","author":"Y Song","year":"2019","unstructured":"Song Y, Wang Y, Wang Z. Requirement for etoposide in the initial treatment of Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis. Br J Haematol. 2019;186(5):717\u201323.","journal-title":"Br J Haematol"},{"key":"3182_CR5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.semcancer.2014.01.002","volume":"26","author":"SC Kenney","year":"2014","unstructured":"Kenney SC, Mertz JE. Regulation of the latent-lytic switch in Epstein-Barr virus. Semin Cancer Biol. 2014;26:60\u20138.","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"3182_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41564-017-0080-8","volume":"3","author":"H Zhang","year":"2018","unstructured":"Zhang H, et al. Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry. Nat Microbiol. 2018;3(2):1\u20138.","journal-title":"Nat Microbiol"},{"issue":"3","key":"3182_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1040-8428(02)00117-8","volume":"44","author":"S Imashuku","year":"2002","unstructured":"Imashuku S. Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol. 2002;44(3):259\u201372.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"3182_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/bjh.17638","volume":"196","author":"NK El-Mallawany","year":"2022","unstructured":"El-Mallawany NK, Curry CV, Allen CE. Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomes. Br J Haematol. 2022;196(1):31\u201344.","journal-title":"Br J Haematol"},{"issue":"3","key":"3182_CR9","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/bjh.16861","volume":"191","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, et al. L-DEP regimen salvage therapy for paediatric patients with refractory Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis. Br J Haematol. 2020;191(3):453\u20139.","journal-title":"Br J Haematol"},{"issue":"7","key":"3182_CR10","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1182\/blood-2002-01-0172","volume":"100","author":"JI Henter","year":"2002","unstructured":"Henter JI, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood. 2002;100(7):2367\u201373.","journal-title":"Blood"},{"issue":"12","key":"3182_CR11","doi-asserted-by":"publisher","first-page":"e630","DOI":"10.1016\/S2352-3026(19)30156-5","volume":"6","author":"A Ahmed","year":"2019","unstructured":"Ahmed A, et al. Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial. Lancet Haematol. 2019;6(12):e630\u20137.","journal-title":"Lancet Haematol"},{"issue":"9","key":"3182_CR12","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/ajh.21795","volume":"85","author":"JS Ahn","year":"2010","unstructured":"Ahn JS, et al. Clinical significance of clonality and Epstein-Barr virus infection in adult patients with hemophagocytic lymphohistiocytosis. Am J Hematol. 2010;85(9):719\u201322.","journal-title":"Am J Hematol"},{"issue":"1","key":"3182_CR13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13045-016-0317-7","volume":"9","author":"J Wang","year":"2016","unstructured":"Wang J, et al. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Hematol Oncol. 2016;9(1):84.","journal-title":"J Hematol Oncol"},{"issue":"19","key":"3182_CR14","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1182\/blood-2015-05-644914","volume":"126","author":"Y Wang","year":"2015","unstructured":"Wang Y, et al. Multicenter study of combination DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis. Blood. 2015;126(19):2186\u201392.","journal-title":"Blood"},{"issue":"2","key":"3182_CR15","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124\u201331.","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"3182_CR16","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/pbc.24980","volume":"61","author":"K Kogawa","year":"2014","unstructured":"Kogawa K, et al. Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group. Pediatr Blood Cancer. 2014;61(7):1257\u201362.","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"3182_CR17","first-page":"148","volume":"30","author":"G Hao","year":"2024","unstructured":"Hao G, et al. Clinical laboratory Analysis of EB Virus Associated Hemophagocytic Lymphohistiocytosis in Children. Altern Ther Health Med. 2024;30(5):148\u201354.","journal-title":"Altern Ther Health Med"},{"issue":"23","key":"3182_CR18","doi-asserted-by":"publisher","first-page":"7258","DOI":"10.1182\/bloodadvances.2023010546","volume":"7","author":"B Verkamp","year":"2023","unstructured":"Verkamp B, et al. Early response markers predict survival after etoposide-based therapy of hemophagocytic lymphohistiocytosis. Blood Adv. 2023;7(23):7258\u201369.","journal-title":"Blood Adv"},{"issue":"1","key":"3182_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/pbc.24188","volume":"60","author":"RA Marsh","year":"2013","unstructured":"Marsh RA, et al. Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab. Pediatr Blood Cancer. 2013;60(1):101\u20139.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"3182_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12985-025-02741-7","volume":"22","author":"H Yan","year":"2025","unstructured":"Yan H, et al. Active EBV infection in children: associations between DNA load, infection status, immune status, and disease severity. Virol J. 2025;22(1):113.","journal-title":"Virol J"},{"issue":"5","key":"3182_CR21","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s12185-019-02641-x","volume":"109","author":"R Yanagisawa","year":"2019","unstructured":"Yanagisawa R, et al. Correction to: Factors predicting the recurrence of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children after treatment using the HLH-2004 protocol. Int J Hematol. 2019;109(5):629.","journal-title":"Int J Hematol"},{"issue":"8","key":"3182_CR22","doi-asserted-by":"publisher","first-page":"e29097","DOI":"10.1002\/pbc.29097","volume":"68","author":"N Tang","year":"2021","unstructured":"Tang N, et al. Polymorphisms and haplotypes of IL2RA, IL10, IFNG, IRF5, and CCR2 are associated with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children. Pediatr Blood Cancer. 2021;68(8):e29097.","journal-title":"Pediatr Blood Cancer"},{"issue":"23","key":"3182_CR23","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1182\/blood.2018894618","volume":"133","author":"P La Rosee","year":"2019","unstructured":"La Rosee P, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019;133(23):2465\u201377.","journal-title":"Blood"},{"issue":"9","key":"3182_CR24","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/art.38690","volume":"66","author":"L Fardet","year":"2014","unstructured":"Fardet L, et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014;66(9):2613\u201320.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"3182_CR25","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00277-023-05606-7","volume":"103","author":"C Feng","year":"2024","unstructured":"Feng C, et al. A convenient and practical index for predicting the induction response in adult patients with hemophagocytic lymphohistiocytosis: ferritin\/platelet ratio. Ann Hematol. 2024;103(3):715\u201323.","journal-title":"Ann Hematol"},{"issue":"3","key":"3182_CR26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jmii.2011.01.027","volume":"44","author":"YT Tseng","year":"2011","unstructured":"Tseng YT, et al. Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults. J Microbiol Immunol Infect. 2011;44(3):191\u20137.","journal-title":"J Microbiol Immunol Infect"},{"key":"3182_CR27","doi-asserted-by":"crossref","unstructured":"Gan J et al. Development and Validation of a LASSO-Logistic Regression Model for Predicting Disseminated Intravascular Coagulation in Pediatric Hemophagocytic Lymphohistiocytosis. Shock, 2026.","DOI":"10.1097\/SHK.0000000000002776"},{"issue":"11","key":"3182_CR28","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1182\/blood.2019003886","volume":"135","author":"P Liu","year":"2020","unstructured":"Liu P, et al. Nivolumab treatment of relapsed\/refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults. Blood. 2020;135(11):826\u201333.","journal-title":"Blood"},{"issue":"1","key":"3182_CR29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4049\/jimmunol.1302282","volume":"192","author":"TS Johnson","year":"2014","unstructured":"Johnson TS, et al. Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis. J Immunol. 2014;192(1):84\u201391.","journal-title":"J Immunol"},{"issue":"2","key":"3182_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S1471-4906(01)02149-4","volume":"23","author":"H Fickenscher","year":"2002","unstructured":"Fickenscher H, et al. The interleukin-10 family of cytokines. Trends Immunol. 2002;23(2):89\u201396.","journal-title":"Trends Immunol"},{"issue":"5","key":"3182_CR31","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.jaci.2022.06.017","volume":"150","author":"Y Tang","year":"2022","unstructured":"Tang Y, et al. Excessive IL-10 and IL-18 trigger hemophagocytic lymphohistiocytosis-like hyperinflammation and enhanced myelopoiesis. J Allergy Clin Immunol. 2022;150(5):1154\u201367.","journal-title":"J Allergy Clin Immunol"},{"key":"3182_CR32","doi-asserted-by":"crossref","unstructured":"Xu XJ et al. Diagnostic accuracy of a specific cytokine pattern in hemophagocytic lymphohistiocytosis in children. J Pediatr. 2012;160(6):984\u201390 e981.","DOI":"10.1016\/j.jpeds.2011.11.046"},{"issue":"1","key":"3182_CR33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1365-2141.2008.07298.x","volume":"143","author":"Y Tang","year":"2008","unstructured":"Tang Y, et al. Early diagnostic and prognostic significance of a specific Th1\/Th2 cytokine pattern in children with haemophagocytic syndrome. Br J Haematol. 2008;143(1):84\u201391.","journal-title":"Br J Haematol"},{"key":"3182_CR34","doi-asserted-by":"publisher","first-page":"850443","DOI":"10.3389\/fimmu.2022.850443","volume":"13","author":"XJ Xu","year":"2022","unstructured":"Xu XJ, et al. Simple Evaluation of Clinical Situation and Subtypes of Pediatric Hemophagocytic Lymphohistiocytosis by Cytokine Patterns. Front Immunol. 2022;13:850443.","journal-title":"Front Immunol"},{"issue":"3","key":"3182_CR35","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","volume":"119","author":"H Kimura","year":"2012","unstructured":"Kimura H, et al. EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood. 2012;119(3):673\u201386.","journal-title":"Blood"},{"issue":"1","key":"3182_CR36","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/infdis\/jiaf065","volume":"232","author":"X Fang","year":"2025","unstructured":"Fang X, et al. High Epstein-Barr Virus DNA Load in T Cells Predicts Hemophagocytic Lymphohistiocytosis. J Infect Dis. 2025;232(1):212\u20139.","journal-title":"J Infect Dis"},{"issue":"6","key":"3182_CR37","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1007\/s10875-023-01493-9","volume":"43","author":"J Zhang","year":"2023","unstructured":"Zhang J, et al. The Clinical Significance and Prognostic Role of Whole-Blood Epstein-Barr Virus DNA in Lymphoma-Associated Hemophagocytic Lymphohistiocytosis. J Clin Immunol. 2023;43(6):1302\u201310.","journal-title":"J Clin Immunol"},{"issue":"3","key":"3182_CR38","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/hon.2998","volume":"40","author":"M Zheng","year":"2022","unstructured":"Zheng M, et al. The superiority of Epstein-Barr virus DNA in plasma over in peripheral blood mononuclear cells for monitoring EBV-positive NK-cell lymphoproliferative diseases. Hematol Oncol. 2022;40(3):381\u20139.","journal-title":"Hematol Oncol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-026-03182-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-026-03182-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-026-03182-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T02:22:30Z","timestamp":1786587750000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12985-026-03182-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3182"],"URL":"https:\/\/doi.org\/10.1186\/s12985-026-03182-6","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"2 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was reviewed and approved by the Medical Ethics Committee of the Hunan Children\u2019s Hospital (HCHLL-2022-127). The information used in this study was sourced from the electronic medical record system, ensuring patient confidentiality was maintained. The requirement for written informed consent was waived by the Medical Ethics Committee of the Hunan Children\u2019s Hospital.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"194"}}